These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 18033962)

  • 1. Identification of responders to rivastigmine: a prospective cohort study.
    Lemstra AW; Kuiper RB; Schmand B; van Gool WA
    Dement Geriatr Cogn Disord; 2008; 25(1):60-6. PubMed ID: 18033962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting.
    Frankfort SV; Appels BA; De Boer A; Tulner LR; Van Campen JP; Koks CH; Beijnen JH
    Int J Clin Pract; 2006 Jun; 60(6):646-54. PubMed ID: 16805746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
    Burn D; Emre M; McKeith I; De Deyn PP; Aarsland D; Hsu C; Lane R
    Mov Disord; 2006 Nov; 21(11):1899-907. PubMed ID: 16960863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term rivastigmine treatment in a routine clinical setting.
    Minthon L; Wallin AK; Eriksson S; Wattmo C; Andreasen N
    Acta Neurol Scand; 2009 Mar; 119(3):180-5. PubMed ID: 18759798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of responders and reactive domains to rivastigmine in Alzheimer's disease.
    Frankfort SV; Appels BA; de Boer A; Tulner LR; van Campen JP; Koks CH; Beijnen JH; Schmand BA
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):545-51. PubMed ID: 17109476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia.
    Gurevich TY; Shabtai H; Korczyn AD; Simon ES; Giladi N
    Mov Disord; 2006 Oct; 21(10):1663-6. PubMed ID: 16941467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of rivastigmine in routine clinical practice.
    Frankfort SV; Appels BA; de Boer A; Tulner LR; van Campen JP; Koks CH; Beijnen JH
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1167-71. PubMed ID: 16315150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlates.
    Ehrt U; Brønnick K; De Deyn PP; Emre M; Tekin S; Lane R; Aarsland D
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):980-5. PubMed ID: 17393542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rivastigmine in a case of autopsy proved frontotemporal dementia (Pick's disease)].
    Calatayud-Noguera T; Astudillo-González A; Alvarez-Carriles JC; Temprano-Fernández T; Cortés-Velarde M; Oliva-Nacarino P
    Rev Neurol; 2009 Jun 1-15; 48(11):582-4. PubMed ID: 19472156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients.
    Barone P; Burn DJ; van Laar T; Hsu C; Poewe W; Lane RM
    Mov Disord; 2008 Aug; 23(11):1532-40. PubMed ID: 18581467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rivastigmine solution prescribing habits in patients with Alzheimer-type dementia in Spain (RIVASOL study)].
    González-Gutiérrez JL; Gobartt AL;
    Rev Neurol; 2007 Jun 16-30; 44(12):705-10. PubMed ID: 17583861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between measures of dementia severity and observation of daily life functioning as measured with the Assessment of Motor and Process Skills (AMPS).
    Bouwens SF; van Heugten CM; Aalten P; Wolfs CA; Baarends EM; van Menxel DA; Verhey FR
    Dement Geriatr Cogn Disord; 2008; 25(1):81-7. PubMed ID: 18042994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
    Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivastigmine in Parkinson's disease dementia.
    Chitnis S; Rao J
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):941-55. PubMed ID: 19619073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
    Mohs RC; Shiovitz TM; Tariot PN; Porsteinsson AP; Baker KD; Feldman PD
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):752-9. PubMed ID: 19700948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two years' follow-up of rivastigmine treatment in Huntington disease.
    de Tommaso M; Difruscolo O; Sciruicchio V; Specchio N; Livrea P
    Clin Neuropharmacol; 2007; 30(1):43-6. PubMed ID: 17272969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivastigmine augmentation in the management of chronic schizophrenia with comorbid dementia: an open-label study investigating effects on cognition, behaviour and activities of daily living.
    Mendelsohn E; Rosenthal M; Bohiri Y; Werber E; Kotler M; Strous RD
    Int Clin Psychopharmacol; 2004 Nov; 19(6):319-24. PubMed ID: 15486516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of delusional misidentification syndromes in Parkinson's disease with dementia.
    Pagonabarraga J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Kulisevsky J
    Mov Disord; 2008 Feb; 23(3):443-8. PubMed ID: 18076112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domperidone is effective in the prevention of rivastigmine-related gastrointestinal disturbances.
    Scarzella L; Costanza A; Vastola K
    Funct Neurol; 2007; 22(2):101-4. PubMed ID: 17637213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.